A PHASE 3 OPEN-LABEL EXTENSION STUDY TO ASSESS THE LONG-TERM SAFETY AND EFFICACY OF INTRAVENOUS ATB200 CO-ADMINISTERED WITH ORAL AT2221 IN ADULT SUBJECTS WITH LATE-ONSET POMPE DISEASE
Administered By
Awarded By
Contributors
- Kishnani, Priya Sunil Principal Investigator
Start/End
- April 13, 2020 - November 30, 2024